Literature DB >> 15454290

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.

Luis A Videla1, Ramón Rodrigo, Julia Araya, Jaime Poniachik.   

Abstract

Human nonalcoholic fatty liver disease (NAFLD) associated with obesity is characterized by depletion of hepatic n-3 long-chain polyunsaturated fatty acids (LCPUFA), with lower LCPUFA product/precursor ratios and higher 18:1n-9 trans levels in adipose tissue, both in patients with steatosis and in those with steatohepatitis. These changes point to modification of gene expression, with decreased fatty acid oxidation and triacylglycerol export and enhanced lipid synthesis, thereby leading to fat accumulation in the liver. Changes in oxidative stress-related parameters indicate a moderate enhancement in the pro-oxidant status of the liver in steatosis, which is further exacerbated in steatohepatitis. It is proposed that oxidative stress plays a dual role in NAFLD by contributing to steatosis due to higher peroxidation of LCPUFA, in addition to defective fatty acid desaturation and diet imbalance, and by promoting progression of steatosis to steatohepatitis, features that might involve changes in the activity of transcriptional mediators.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454290     DOI: 10.1016/j.freeradbiomed.2004.06.033

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  64 in total

1.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

2.  Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.

Authors:  Bokai Lei; Weibin Zha; Yun Wang; Cong Wen; Elaine J Studer; Xuan Wang; Fang Jin; Guangji Wang; Luyong Zhang; Huiping Zhou
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 3.  Thyroid hormone analogues and derivatives: Actions in fatty liver.

Authors:  Maria Coppola; Daniela Glinni; Maria Moreno; Federica Cioffi; Elena Silvestri; Fernando Goglia
Journal:  World J Hepatol       Date:  2014-03-27

4.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

5.  Gestational and lactational exposure to dichlorinated bisphenol A induces early alterations of hepatic lipid composition in mice.

Authors:  Dounia El Hamrani; Amandine Chepied; William Même; Marc Mesnil; Norah Defamie; Sandra Même
Journal:  MAGMA       Date:  2018-02-20       Impact factor: 2.310

6.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

7.  Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.

Authors:  Changfeng Hu; Yiqi Wang; Yongsheng Fan; Haichang Li; Chunyan Wang; Jida Zhang; Shuijuan Zhang; Xianlin Han; Chengping Wen
Journal:  AAPS J       Date:  2015-03-12       Impact factor: 4.009

8.  OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Michael Berk; Lisa Yerian; Rocio Lopez; Yoon-Mi Chung; Renliang Zhang; Thomas M McIntyre; Ariel E Feldstein; Stanley L Hazen
Journal:  Dig Dis Sci       Date:  2014-01-25       Impact factor: 3.199

Review 9.  Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Authors:  Naim Alkhouri; Ariel E Feldstein
Journal:  Metabolism       Date:  2016-02-02       Impact factor: 8.694

10.  Liver proteome analysis in a rodent model of alcoholic steatosis.

Authors:  Billy W Newton; William K Russell; David H Russell; Shashi K Ramaiah; Arul Jayaraman
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.